Form 4: Rhythm Pharmaceuticals Director Jennifer L. Good Reports Stock Unit Vesting
SEC Filing
Director Jennifer L. Good reported the vesting of 3,000 restricted stock units into common stock of Rhythm Pharmaceuticals on June 21, 2024.
Summary
- On June 21, 2024, Jennifer L. Good, a director of Rhythm Pharmaceuticals, reported the vesting of 3,000 restricted stock units.
- These units converted into 3,000 shares of Rhythm Pharmaceuticals common stock.
- The transaction was reported on a Form 4 filed with the SEC on June 25, 2024.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard compensation practice. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted compensation.
Stakeholder Impact
- The vesting of stock units may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Restricted stock units fully vested |
| 06/25/2024 | Form 4 filing date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.